NCT05210959 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Caçola P, Gabbard C, Santos DC, Batistela AC
Development of the Affordances in the Home Environment for Motor Development-Infant Scale. Pediatr Int. 2011 Dec;53(6):820-5. doi: 10.1111/j.1442-200X.2011.03386.x.
Caçola PM, Gabbard C, Montebelo MI, Santos DC
Further Development and Validation of the Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS). Phys Ther. 2015 Jun;95(6):901-23. doi: 10.2522/ptj.20140011. Epub 2014 Dec 18.
Dinkel D, Snyder K, Cacola P
Affordances in the Home Environment for Motor Development-Infant Scale, Spanish Translation. Early Child Dev Care. 2019;189(5):802-810. doi: 10.1080/03004430.2017.1344653. Epub 2017 Jun 28.
Kavousipor S, Rassafiani M, Ebadi A, Solimani F, Hosseini A, Gabbard C
Cultural Adaptation and Psychometric Properties of the Persian Version of the Affordance in the Home Environment for Motor Development. Iran J Child Neurol. 2019 Winter;13(1):25-35.

Reliability and Validity of the Turkish Version of the Affordances in the Home Environment for Motor Development-Infant Scale and Its Cultural Adaptation in Turkish Population

Details for clinical trial NCT05210959

Clinical trial NCT05210959 - References